About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in San Francisco | 5,211 Studies Near You

Clinical TrialsSan Francisco

Clinical Trials in San Francisco

Discover 5,211 clinical trials near San Francisco, California. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3961-3980 of 5,211 trials

SuspendedA Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV DrugsThis study will look at whether emtricitabine is as safe and effective as abacavir (ABC) when taken with stavudine (d4T) and efavirenz (EFV) in patients who have never taken…NCT00002362·Sacramento, California and 9 others UnknownUsing Heavy Water to Study Cell Dynamics in Parkinson's DiseaseThis pilot study will assess the feasibility of using heavy water as a safe 'tracer' for biomarker studies of diseases of the brain and spinal cord, that, together, are also…NCT00990379·San Francisco, California

Find Trials by Condition in San Francisco

Breast Cancerin San Francisco Lung Cancerin San Francisco Prostate Cancerin San Francisco Colorectal Cancerin San Francisco Melanomain San Francisco Leukemiain San Francisco Lymphomain San Francisco Pancreatic Cancerin San Francisco Ovarian Cancerin San Francisco Brain Cancerin San Francisco

Data from ClinicalTrials.govTerms

RecruitingA Study of GNTI-122 in Adults Recently Diagnosed With T1DThis is a 78-week single arm, multi-center, Phase 1 study to evaluate the safety, tolerability, cellular kinetics, and biomarker changes in C-peptide over time of GNTI-122, an…NCT06919354·Duarte, California and 9 others

TerminatedEfficacy and Safety of AMG0001 in Subjects With Critical Limb IschemiaStudy to Evaluate the Efficacy and Safety of AMG0001 in Subjects with Critical Limb Ischemia.NCT02144610·Tucson, Arizona and 59 others

CompletedStudy on Use of Xylitol-wipes to Prevent Dental CariesMutans streptococci (MS) and lactobacillus species (LB) are the two groups of infectious cariogenic (caries-causing) bacteria most strongly associated with dental caries (dental…NCT01468727·San Francisco, California

CompletedTrametinib With GSK2141795 in BRAF Wild-type MelanomaThis is a multicenter phase II clinical study of trametinib in combination with GSK2141795 in patients with BRAF wild-type mutation melanoma.NCT01941927·San Francisco, California and 1 other

Active not recruitingAngiotensin II in Liver TransplantationThe purpose of this study is to determine the efficacy and safety of Angiotensin II as a second-line vasopressor (drug that raises the blood pressure) during liver transplantation.NCT04901169·San Francisco, California

CompletedProphylactic Antibiotic Regimens in Tumor Surgery (PARITY)The Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) trial is the first ever international multi-center randomized controlled trial in bone cancer surgery.NCT01479283·Little Rock, Arkansas and 53 others

CompletedA Study of Tazemetostat in Adult Participants With Soft Tissue SarcomaThis study will include participants with various types of cancer known as soft-tissue sarcomas.NCT02601950·San Francisco, California and 31 others

CompletedCovered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the AortaCoarctation of the aorta (CoA) is a congenital abnormality producing obstruction to blood flow through the aorta.NCT01278303·San Diego, California and 18 others

RecruitingAzithromycin Prophylaxis for PRElabor CEsarean DElivery TrialThis is a phase-III multi-center double-blind randomized controlled trial of 8,000 individuals undergoing a scheduled or prelabor cesarean delivery who are randomized to either…NCT06605118·Birmingham, Alabama and 13 others

CompletedSafety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear PalsyThis study will evaluate the safety and tolerability (maximum tolerated dose (MTD) within the specified dosing range) of single intravenous (IV) infusion of C2N-8E12 in patients…NCT02494024·Birmingham, Alabama and 11 others

Not yet recruitingEfficacy and Safety of Shatavari Root Extract for Premenstrual Syndrome in WomenPremenstrual syndrome (PMS) is a common condition that affects women of reproductive age and is associated with emotional, physical, and behavioral symptoms such as mood swings…NCT07441096·San Francisco, California

UnknownTrial of Myocet in Metastatic Breast CancerThe purpose of the study is to examine the safety and effectiveness of the drug combination of Myocet, paclitaxel and trastuzumab compared to paclitaxel and trastuzumab without…NCT00294996·San Diego, California and 104 others

RecruitingRadial vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH)This is a phase IV, prospective, open label, randomized-controlled study that will compare radial access with state-of-the-art femoral access in patients without ST-segment…NCT04077762·San Francisco, California and 5 others

Active not recruitingA Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)The goal of this study is to evaluate intismeran autogene plus pembrolizumab versus placebo plus pembrolizumab for the adjuvant treatment of margin negative, completely resected…NCT06077760·Anchorage, Alaska and 228 others

RecruitingTesting the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland CancersThis phase II trial compares the effect of usual treatment of docetaxel chemotherapy plus trastuzumab, to ado-emtansine (T-DM1) in patients with HER2-postive salivary gland cancer…NCT05408845·Birmingham, Alabama and 151 others

UnknownEducation Program to Promote Female Condom UseThe female condom offers women a potentially important option for HIV prevention.NCT00062634·San Francisco, California

CompletedCivacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.The purpose of this study is to test the safety and efficacy of Civacir® to prevent the recurrence of Hepatitis C Virus (HCV) after liver transplant.NCT01804829·Los Angeles, California and 22 others

Active not recruitingGuaranteed Income to Boost HIV Care Continuity and Suppression Post-Jail ReleaseThe goal of this clinical trial is to understand the implementation requirements and potential health impacts of a guaranteed income (GI) intervention targeting people living with…NCT07115901·San Francisco, California

PreviousPage 199 of 261Next

Diabetes

in San Francisco

Heart Diseasein San Francisco